Smartkarma AI Primers, Smartkarma

αSK Primers

Smartkarma AI Primers

Smartkarma

Smartkarma unites the fragmented investment industry, connecting institutional investors, independent research providers, and corporates within a single network.

Research Reinvented

Equity Bottom-Up

Amarin Corporation Plc / Equity Bottom-Up

<ul>
  <li>Amarin is a single-product biopharmaceutical company focused on its fish oil-derived cardiovascular drug, VASCEPA®/VAZKEPA® (icosapent ethyl).</li>
  <li>The company's growth trajectory has been significantly altered by the loss of patent protection and subsequent generic competition for Vascepa in the United States, its primary market.</li>
  <li>Future prospects are now heavily dependent on the successful commercialization of Vazkepa in Europe and other international markets, a strategy recently shifted to a partnership model with Recordati S.p.A. to accelerate growth and reduce costs.</li>
</ul><p><em>This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.</em></p>


  Amarin is a single-product biopharmaceutical company focused on its fish oil-derived cardiovascular drug, VASCEPA®/VAZKEPA® (icosapent ethyl).
  The company's growth trajectory has been significantly altered by the loss of patent protection and subsequent generic competition for Vascepa in the United States, its primary market.
  Future prospects are now heavily dependent on the successful commercialization of Vazkepa in Europe and other international markets, a strategy recently shifted to a partnership model with Recordati S.p.A. to accelerate growth and reduce costs.
This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Primer: Amarin Corporation Plc (AMRN US) - Aug 2026

United States

Amarin Corporation PLC develops, manufactures, and distributes biopharmaceutical therapeutics. The Company markets its products used in the treatment of cardiovascular diseases to healthcare providers, clinics, researchers, and facilities throughout the world.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Primer: Amarin Corporation Plc (AMRN US) - Aug 2026

Amarin is a single-product biopharmaceutical company focused on its fish oil-derived cardiovascular drug, VASCEPA®/VAZKEPA® (icosapent ethyl). ...

αSK Primers